What is the level of liabilities of Oragenics this year?
Oragenics has a debt balance of 1.8 M USD this year.
Oragenics Liabilities 2024
Oragenics Liabilities
1.8 M USD
Ticker
OGEN
ISIN
US6840233026
WKN
A2JBK2
In 2024, Oragenics's total liabilities amounted to 1.8 M USD, a 2.75% difference from the 1.75 M USD total liabilities in the previous year.
Oragenics Aktienanalyse
What does Oragenics do?
Oragenics Inc is a biopharmaceutical company that focuses on the development of innovative technologies and products for the prevention and treatment of oral and systemic infectious diseases. The company was founded in 1996 as a private company and has since had an impressive track record in the development of diagnostic tools and therapeutics for various diseases in different fields. The company's business model is based on the identification and development of therapeutics that leverage innovative technologies such as bacterial toxins and probiotics. Their products aim to address both the causes of disease formation and the symptoms, contributing to improved patient well-being. Oragenics maintains partnerships and collaborations with other companies and research institutions to enhance its research and development efforts. The company is divided into multiple divisions, including the development of probiotic bacterial groups with specific immunotherapeutic functions, the development of biopharmaceutical products for the treatment of infectious diseases, and the development of diagnostics and screening tools for identifying oral infections. Oragenics has developed a range of products and technologies that can contribute to the improvement of oral and overall health, including a Streptococcus mutans detection system for dentists to identify and combat bacteria in the patient's mouth. One notable product is the TerraCoV2 COVID-19 vaccine, developed in collaboration with the National University of Singapore. Overall, Oragenics Inc has a remarkable track record in the development of innovative technologies and products, emphasizing product quality, rational manufacturing, and a wide range of medical devices. The company works closely with partners and collaborators to intensify its research and development efforts and provide innovative solutions and products. Oragenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing Oragenics's Liabilities
Oragenics's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Oragenics's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing Oragenics's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
Oragenics's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in Oragenics’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about Oragenics stock
What were the liabilities of Oragenics compared to the previous year?
The liabilities of Oragenics have increased by 2.75% increased compared to the previous year.
What are the consequences of high debt for investors of Oragenics?
High liabilities can pose a risk for investors of Oragenics, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in Oragenics?
Low liabilities mean that Oragenics has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of Oragenics affect the company?
An increase in liabilities of Oragenics can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of Oragenics affect the company?
A decrease in the liabilities of Oragenics can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of Oragenics?
Some factors that can influence the liabilities of Oragenics include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of Oragenics so important for investors?
The liabilities of Oragenics are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can Oragenics take to modify the liabilities?
To change its liabilities, Oragenics can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does Oragenics pay?
Over the past 12 months, Oragenics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oragenics is expected to pay a dividend of 0 USD.
What is the dividend yield of Oragenics?
The current dividend yield of Oragenics is .
When does Oragenics pay dividends?
Oragenics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Oragenics?
Oragenics paid dividends every year for the past 0 years.
What is the dividend of Oragenics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Oragenics located?
Oragenics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Oragenics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Oragenics from 12/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/25/2024.
When did Oragenics pay the last dividend?
The last dividend was paid out on 12/25/2024.
What was the dividend of Oragenics in the year 2023?
In the year 2023, Oragenics distributed 0 USD as dividends.
In which currency does Oragenics pay out the dividend?
The dividends of Oragenics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Oragenics
Our stock analysis for Oragenics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oragenics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
